Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 151–200 of 3,104 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05691608	MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2(MAPPYACTS2)	recruiting	N/A	1,800	Gustave Roussy, Cancer Campus, Grand ParisOTHER	1	Sep 14, 2026	clinicaltrials
NCT06511141	Sacral Neuromodulation for Male Overactive Bladder (MOAB)	recruiting	N/A	150	Axonics, Inc.INDUSTRY	1	Sep 14, 2026	clinicaltrials